After graduating from Yale with a B.A. in Economics, Richard Kimball spent over two and a half decades advising healthcare organizations on strategy and capital structure and leading and building both early stage and more established businesses. Kimball started at Morgan Stanley and rose to managing director.
More recently he was chief strategy and growth officer at Accretive Health. He is a trustee of The Brookings Institution, a fellow in Stanford University’s Distinguished Careers Institute and a member of the Young President’s Organization. Kimball is currently CEO of HEXL, a population health management company.
Learn more by visiting the Richard Kimball blog.
